Global Lice Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Lice Treatment Market, By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, Others), Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, Other), Route of Administration (Oral, Topical, Others), Dosage Form (Tablets, Shampoos, lotions, cream, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

 

Lice Treatment Market

Market Analysis and Size

In recent years, the lice treatment market is anticipated to grow rapidly during the forecast period. According to a UN survey released in 2019, the number of children under the age of 14 is anticipated to surpass 2.02 billion in 2019 and reach 2.06 billion by 2050. Because of the large number of people who are susceptible to lice infestation, the market is expected to develop. Lice is a parasite that feeds on human blood and thrives primarily on the head or public areas. Most lice treatments must be applied twice, seven to ten days apart, and nits must be removed by combing damp hair with a fine-toothed comb.

Data Bridge Market Research analyses that the lice treatment market was valued at USD 93.47 million in 2021 and is expected to reach USD 156.44 million by 2029, registering a CAGR of 6.65% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Lice are wingless, blood-sucking insects that feed on the blood of humans and live on their heads or scalps. When lice suck blood from people, they inject saliva. Blood coagulation is prevented by injecting saliva. Pruritus is a disease caused by lice saliva entering the human circulatory system. The lice's saliva may trigger severe allergic reactions in some people, and the lice's sharp claws can cause itching and pain by moving through hair strands. Lice treatments (called pediculicides) are accessible without a prescription or over the counter. Shampoos, lotions, and cream rinses are among them.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, Others), Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, Other), Route of Administration (Oral, Topical, Others), Dosage Form (Tablets, Shampoos, lotions, cream, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), AstraZeneca (UK), Johnson & Johnson (US), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (US), Edenbridge Pharmaceuticals, LLC (US), ParaPRO LLC (US), Encube Ethicals (India), GALDERMA (Switzerland), Alliance Pharmaceuticals (UK), Foamix Pharmaceuticals Ltd (US), Arbor Pharmaceuticals (US), Dr. Reddy's Laboratories Ltd. (India), Perrigo Company plc (Ireland)

Market Opportunities

 

  • Increase in the number of emerging markets
  • Increase in the number of research and development activities
  • Rising investment for the development of advanced technologies
  • Surging drug approvals and launches

Lice Treatment Market Dynamics

Drivers

  • Increasing cases of head lice across the globe

The rising head lice cases across the globe are estimated to enhance the lice treatment market's growth. Head lice are known to transmit any disease, yet they do not transmit infections. They can cause excruciating itching and subsequent skin diseases. Sleep loss, extreme itching, discomfort, and a loss of attention on important tasks are among well-known side symptoms of head lice. These factors are fueling the global lice treatment market's expansion.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of lice treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness and increasing prevalence of lice parasites contamination will expand the lice treatment market. Additionally, surging awareness towards health and rising adoption rate of over-the counter drugs will result in the expansion of lice treatment market.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the lice treatment market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate. 

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the lice treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the lice treatment market. Additionally, strict regulatory policies and lack of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This lice treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lice treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Lice treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Lice Treatment Market

Over the projected period, the lice treatment market was expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the lice treatment market.

Recent Development

  • In October 2020, U.S. Food and Drug Administration (FDA) had announced the approval of a lotion used in the treatment of head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The prescription drug manufacturer usually initiates the changeover from prescription to over-the-counter. The evidence presented must demonstrate that the drug is safe and effective when used as instructed in the proposed labelling for it to be switched from prescription to nonprescription status. According to the company, consumers must be able to grasp how to use the drug safely and efficiently without the assistance of a healthcare expert.

Global Lice Treatment Market Scope

The lice treatment market is segmented on the basis of type, treatment, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Pediculosis Capitis
  • Pediculosis Corporis
  • Pediculosis Pubis
  • Others

Treatment

  • Ivermectin
  • Spinosad
  • Permethrin
  • Pyrethrin
  • Other

Dosage form

  • Tablets
  • Shampoos
  • Lotions
  • Cream
  • Others

Route of Administration

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Lice Treatment Market Regional Analysis/Insights

The lice treatment market is analysed and market size insights and trends are provided by country, type, treatment, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the lice treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the lice treatment market because of the growing children population and presence of major key players in this region. Additionally, rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to presence of generic manufacturers in this region. Also, the development of healthcare infrastructure and increasing lice contamination will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Lice Treatment Market Share Analysis

The Lice treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lice treatment market.

Some of the major players operating in the lice treatment market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France), Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • AstraZeneca (UK)
  • Johnson & Johnson (US)
  • Bayer AG (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Eli Lilly and Company (US)
  • Edenbridge Pharmaceuticals, LLC (US)
  • ParaPRO LLC (US)
  • Encube Ethicals (India)
  • GALDERMA (Switzerland)
  • Alliance Pharmaceuticals (UK)
  • Foamix Pharmaceuticals Ltd (US)
  • Arbor Pharmaceuticals (US)
  • Dr. Reddy's Laboratories Ltd. (India)
  • Perrigo Company plc (Ireland)

Research Methodology: Global Lice Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The market value for Lice Treatment Market is expected USD 156.44 million by 2029.
The Lice Treatment Market is to grow at a CAGR of 6.65% during the forecast by 2029.
The major players operating in the Lice Treatment Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), AstraZeneca (UK), Johnson & Johnson (US), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (US), Edenbridge Pharmaceuticals, LLC (US), ParaPRO LLC (US), Encube Ethicals (India), GALDERMA (Switzerland), Alliance Pharmaceuticals (UK), Foamix Pharmaceuticals Ltd (US), Arbor Pharmaceuticals (US), Dr. Reddy's Laboratories Ltd. (India), Perrigo Company plc (Ireland).
The major countries covered in the Lice Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.